XGN
Price:
$4.1
Market Cap:
$72.31M
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2019-09-19
Stock Exchange
NASDAQ
Ticker
XGN
According to Exagen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 73.55M. This represents a change of 114.66% compared to the average of 34.26M of the last 4 quarters.
The mean historical Enterprise Value of Exagen Inc. over the last ten years is 62.15M. The current 73.55M Enterprise Value has changed 11.73% with respect to the historical average. Over the past ten years (40 quarters), XGN's Enterprise Value was at its highest in in the December 2019 quarter at 272.81M. The Enterprise Value was at its lowest in in the September 2019 quarter at -28532702.39.
Average
62.15M
Median
18.68M
Minimum
2.17M
Maximum
272.82M
Discovering the peaks and valleys of Exagen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.05%
Maximum Annual Enterprise Value = 272.82M
Minimum Annual Increase = -88.48%
Minimum Annual Enterprise Value = 2.17M
Year | Enterprise Value | Change |
---|---|---|
2023 | 22.41M | 70.97% |
2022 | 13.11M | -88.48% |
2021 | 113.79M | -16.46% |
2020 | 136.22M | -50.07% |
2019 | 272.82M | 2.05% |
2018 | 12.70M | 44.94% |
2017 | 8.77M | -64.31% |
2015 | 24.56M | 64.18% |
2014 | 14.96M | 589.59% |
2013 | 2.17M | 327.16% |
The current Enterprise Value of Exagen Inc. (XGN) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
49.77M
5-year avg
111.67M
10-year avg
62.15M
Exagen Inc.’s Enterprise Value is less than FONAR Corporation (90.09M), greater than Burning Rock Biotech Limited (-29410816.44), less than Sera Prognostics, Inc. (212.96M), less than Olink Holding AB (publ) (3.16B), less than LumiraDx Limited (301.24M), greater than Genetron Holdings Limited (0), less than Castle Biosciences, Inc. (766.68M), less than Sotera Health Company (5.68B), greater than Psychemedics Corporation (13.94M), greater than DarioHealth Corp. (59.29M), less than Biodesix, Inc. (216.75M),
Company | Enterprise Value | Market cap |
---|---|---|
90.09M | $103.11M | |
-29410816.44 | $54.55M | |
212.96M | $214.54M | |
3.16B | $3.24B | |
301.24M | $0 | |
0 | $127.29M | |
766.68M | $834.90M | |
5.68B | $3.63B | |
13.94M | $13.76M | |
59.29M | $28.80M | |
216.75M | $186.20M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exagen Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Exagen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Exagen Inc.'s Enterprise Value?
What is the highest Enterprise Value for Exagen Inc. (XGN)?
What is the 3-year average Enterprise Value for Exagen Inc. (XGN)?
What is the 5-year average Enterprise Value for Exagen Inc. (XGN)?
How does the current Enterprise Value for Exagen Inc. (XGN) compare to its historical average?